Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
$134.83
$134.83
$116.44
$177.88
N/AN/A381,032 shsN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
$44.96
$43.67
$19.59
$44.99
$8.19B1.41.71 million shsN/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
$32.02
-1.2%
$32.11
$23.85
$41.93
$4.63B0.662.61 million shs2.61 million shs
Warrior Met Coal stock logo
HCC
Warrior Met Coal
$50.01
-0.7%
$46.59
$38.00
$75.15
$2.63B0.67838,036 shs892,406 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00%0.00%0.00%0.00%+13,482,999,900.00%
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.00%0.00%0.00%0.00%+11.56%
CNX Resources Corporation. stock logo
CNX
CNX Resources
0.00%-5.33%+2.91%+9.31%+29.06%
Warrior Met Coal stock logo
HCC
Warrior Met Coal
0.00%+14.13%+7.21%+23.47%-31.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/AN/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
3.351 of 5 stars
1.81.00.00.01.93.33.1
Warrior Met Coal stock logo
HCC
Warrior Met Coal
4.2864 of 5 stars
3.31.01.70.02.81.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00
N/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.00
N/AN/AN/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
1.60
Reduce$31.58-1.36% Downside
Warrior Met Coal stock logo
HCC
Warrior Met Coal
2.50
Moderate Buy$63.6727.31% Upside

Current Analyst Ratings Breakdown

Latest CERE, CNX, HCC, and ARCH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$21.00 ➝ $25.00
5/13/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$35.00 ➝ $36.00
5/7/2025
Warrior Met Coal stock logo
HCC
Warrior Met Coal
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$68.00 ➝ $50.00
4/25/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/22/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$22.00 ➝ $21.00
4/15/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$31.00
4/11/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Underperform ➝ Sector Perform$33.00
4/11/2025
Warrior Met Coal stock logo
HCC
Warrior Met Coal
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$86.00 ➝ $76.00
4/7/2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$34.00 ➝ $35.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/A$3.71 per shareN/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
$1.27B3.66$5.23 per share6.12$27.45 per share1.17
Warrior Met Coal stock logo
HCC
Warrior Met Coal
$1.32B1.99$8.00 per share6.25$39.97 per share1.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/A0.00N/AN/AN/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
-$432.84M-$2.73N/AN/AN/AN/A-98.94%-45.07%N/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
-$90.49M-$2.06N/A11.900.30-30.59%7.86%3.71%7/24/2025 (Estimated)
Warrior Met Coal stock logo
HCC
Warrior Met Coal
$250.60M$2.0124.885.58N/A7.98%5.41%4.34%7/30/2025 (Estimated)

Latest CERE, CNX, HCC, and ARCH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
CNX Resources Corporation. stock logo
CNX
CNX Resources
$0.40N/AN/AN/A$467.33 millionN/A
4/30/2025Q1 2025
Warrior Met Coal stock logo
HCC
Warrior Met Coal
-$0.05-$0.16-$0.11-$0.16$296.39 million$299.94 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/AN/A
CNX Resources Corporation. stock logo
CNX
CNX Resources
N/AN/AN/AN/AN/A
Warrior Met Coal stock logo
HCC
Warrior Met Coal
$0.320.64%N/A15.92%1 Years

Latest CERE, CNX, HCC, and ARCH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2025
Warrior Met Coal stock logo
HCC
Warrior Met Coal
quarterly$0.080.65%5/5/20255/5/20255/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.60
10.22
10.22
CNX Resources Corporation. stock logo
CNX
CNX Resources
0.63
0.27
0.25
Warrior Met Coal stock logo
HCC
Warrior Met Coal
0.09
5.14
4.00

Institutional Ownership

CompanyInstitutional Ownership
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
87.73%
CNX Resources Corporation. stock logo
CNX
CNX Resources
95.16%
Warrior Met Coal stock logo
HCC
Warrior Met Coal
92.28%

Insider Ownership

CompanyInsider Ownership
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
5.10%
CNX Resources Corporation. stock logo
CNX
CNX Resources
3.10%
Warrior Met Coal stock logo
HCC
Warrior Met Coal
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/A
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
300182.20 million172.90 millionOptionable
CNX Resources Corporation. stock logo
CNX
CNX Resources
470144.72 million140.24 millionOptionable
Warrior Met Coal stock logo
HCC
Warrior Met Coal
1,33652.56 million51.46 millionOptionable

Recent News About These Companies

HCC Warrior Met Coal, Inc. - Seeking Alpha
Warrior Met Coal, Inc. (HCC): A Bull Case Theory
Warrior Met Coal Posts Q1 Loss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Arch Biopartners stock logo

Arch Biopartners NYSE:ARCH

$134.83 0.00 (0.00%)
As of 01/14/2025

Cerevel Therapeutics stock logo

Cerevel Therapeutics NASDAQ:CERE

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.

CNX Resources stock logo

CNX Resources NYSE:CNX

$32.02 -0.39 (-1.20%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$31.99 -0.03 (-0.09%)
As of 07/3/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNX Resources Corporation, an independent natural gas and midstream company, engages in the acquisition, exploration, development, and production of natural gas properties in the Appalachian Basin. The company operates in two segments, Shale and Coalbed Methane (CBM). It produces and sells pipeline quality natural gas primarily for gas wholesalers. The company owns rights to extract natural gas from shale properties in Pennsylvania, West Virginia, and Ohio, as well as rights to extract natural gas from other shale and shallow oil and gas formations in Illinois, Indiana, New York, and Virginia. It also owns rights to extract CBM in Virginia, West Virginia, Pennsylvania, Ohio, Illinois, Indiana, and New Mexico. In addition, the company designs, builds, and operates natural gas gathering systems to move gas from the wellhead to interstate pipelines or other local sales points; owns and operates approximately 2,600 miles of natural gas gathering pipelines, as well as various natural gas processing facilities. It also offers turn-key solutions for water sourcing, delivery, and disposal for its natural gas operations and for third parties. The company was formerly known as CONSOL Energy Inc. and changed its name to CNX Resources Corporation in November 2017. CNX Resources Corporation was founded in 1860 and is headquartered in Canonsburg, Pennsylvania.

Warrior Met Coal stock logo

Warrior Met Coal NYSE:HCC

$50.01 -0.33 (-0.66%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$49.86 -0.16 (-0.31%)
As of 07/3/2025 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.